Загрузка...
Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis
Targeted immune-modulating agents are entering clinical practice in many specialties, providing novel therapeutic possibilities but introducing new potential toxicities. We present the first reported case, to our knowledge, of immune-mediated nephritis following the administration of Tremelimumab (C...
Сохранить в:
| Опубликовано в: : | NDT Plus |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4421243/ https://ncbi.nlm.nih.gov/pubmed/25984021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfp048 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|